James G. Marken's Insider Trades & SAST Disclosures
James G. Marken's most recent trade in ANI Pharmaceuticals Inc was a trade of 11,087 Common Stock done at an average price of $67.7 . Disclosure was reported to the exchange on June 7, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James G. Marken.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 07 Jun 2024 | 11,087 | 117,829 (0%) | 0% | 67.7 | 750,590 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 07 Jun 2024 | 7,250 | 0 | - | - | Stock Option (right to buy) | ||
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 07 Jun 2024 | 7,250 | 123,616 (1%) | 0% | 49.5 | 358,948 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 07 Jun 2024 | 5,300 | 0 | - | - | Stock Option (right to buy) | ||
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 07 Jun 2024 | 5,300 | 128,916 (1%) | 0% | 57.1 | 302,418 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 10 Apr 2024 | 2,799 | 116,006 (0%) | 0% | 67.0 | 187,421 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 23 Mar 2024 | 3,653 | 118,805 (0%) | 0% | 69.6 | 254,176 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 07 Mar 2024 | 24,338 | 124,492 (1%) | 0% | 66.4 | 1,615,313 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 07 Mar 2024 | 2,034 | 122,458 (1%) | 0% | 66.7 | 135,688 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 29 Feb 2024 | 1,058 | 148,830 (1%) | 0% | 67.7 | 71,595 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 14 Feb 2024 | 10,066 | 143,178 (1%) | 0% | 0 | Common Stock | ||
| ANI Pharmaceuticals Inc | Marken G. James | SVP OPS & PROD DEV | 14 Feb 2024 | 6,710 | 149,888 (1%) | 0% | 0 | Common Stock | ||
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 23 Aug 2023 | 3,932 | 133,112 (1%) | 0% | 63 | 247,716 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 23 Aug 2023 | 3,750 | 135,377 (1%) | 0% | 40.6 | 152,213 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 23 Aug 2023 | 3,750 | 0 | - | - | Stock Option (right to buy) | ||
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 23 Aug 2023 | 1,667 | 0 | - | - | Stock Option (right to buy) | ||
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 23 Aug 2023 | 1,667 | 137,044 (1%) | 0% | 33 | 55,011 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 10 Apr 2023 | 2,289 | 131,627 (1%) | 0% | 38.5 | 88,127 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 28 Mar 2023 | 524 | 112,206 (0%) | 0% | 38.6 | 20,237 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 23 Mar 2023 | 2,452 | 112,730 (0%) | 0% | 37.8 | 92,735 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 07 Mar 2023 | 1,951 | 115,691 (0%) | 0% | 44.2 | 86,293 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 07 Mar 2023 | 509 | 115,182 (0%) | 0% | 44.2 | 22,513 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 28 Feb 2023 | 13,026 | 125,232 (1%) | 0% | 0 | Common Stock | ||
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 28 Feb 2023 | 8,684 | 133,916 (1%) | 0% | 0 | Common Stock | ||
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 12 Aug 2022 | 12,894 | 122,814 (1%) | 0% | 37.0 | 477,605 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 12 Aug 2022 | 5,172 | 117,642 (0%) | 0% | 37.8 | 195,464 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 27 Apr 2022 | 6,644 | 135,708 (1%) | 0% | 0 | Common Stock | ||
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 10 Apr 2022 | 1,878 | 129,064 (1%) | 0% | 29.9 | 56,171 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 06 Apr 2022 | 337 | 130,942 (1%) | 0% | 29.7 | 10,006 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 28 Mar 2022 | 524 | 131,279 (1%) | 0% | 28.2 | 14,761 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 24 Mar 2022 | 19,934 | 131,803 (1%) | 0% | 0 | Common Stock | ||
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 12 Apr 2021 | 1,878 | 114,321 (0%) | 0% | 31.9 | 59,833 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 06 Apr 2021 | 337 | 116,199 (0%) | 0% | 33.7 | 11,354 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 29 Mar 2021 | 524 | 116,814 (0%) | 0% | 32.7 | 17,124 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 29 Mar 2021 | 278 | 116,536 (0%) | 0% | 36.1 | 10,047 | Common Stock | |
| ANI Pharmaceuticals Inc | James G. Marken | SVP OPS & PROD DEV | 23 Mar 2021 | 32,041 | 117,338 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges